Pancreatic Cancer Survival Rate: Statistics by Stage & Age

Few cancer diagnoses carry a weight like pancreatic cancer. The numbers can feel stark, but understanding what they actually mean — and what they don’t — is the first step toward making sense of prognosis.

Overall 5-year survival rate: 12% (SEER via NIH) · Stage IV (distant) 5-year survival rate: 3% (Cancer.org) · Stage I (localized) 5-year survival rate: 44% (Cancer.org) · 1-year survival rate: ~10% (Cancer Research UK) · Median survival for late-stage disease: ~1 year (Johns Hopkins)

The table below compiles the key survival rates from authoritative sources.

What is the life expectancy for someone with pancreatic cancer?

Five key numbers frame the answer. The overall 5-year relative survival rate for pancreatic cancer is 12%, according to the SEER program of the National Cancer Institute (US government cancer registry). Johns Hopkins Medicine (academic medical center) puts the combined figure at the same 12%. At one year, Cancer Research UK (UK cancer research charity) reports that around 25% of adults survive one year or more, while only about 5% survive five years or more.

The wide gap between early and late-stage outcomes underlines why stage at diagnosis is the dominant factor.

What’s the worst stage of pancreatic cancer?

Stage IV, where the cancer has spread to distant organs, carries the poorest outlook. The American Cancer Society (leading US cancer organization) reports a 5-year survival rate of 3% for distant-stage disease, compared with 44% for localized (Stage I) and 16% for regional (Stage II/III). The median survival for stage IV is about one year (Johns Hopkins Medicine).

The pattern is clear: late-stage diagnosis drastically limits treatment options and survival.

What are the pancreatic cancer survival rates by age?

Age is a significant prognostic factor. A 2020 study in Scientific Reports (peer-reviewed journal) found that patients aged 20-40 had the best survival, especially when diagnosed early. Johns Hopkins Medicine notes that younger patients tend to do better because they have fewer other health conditions that limit recovery. American Cancer Society data indicate survival decreases with age, with the sharpest drop in patients over 70.

The implication: age modifies prognosis only when early detection makes surgery an option.

How treatable is pancreatic cancer?

Pancreatic cancer remains difficult to treat primarily because most cases are diagnosed after the cancer has already spread. The Cleveland Clinic (nonprofit academic medical center) emphasizes that late diagnosis and the aggressive biology of the disease limit treatment success. Without treatment, survival is typically only a few months (Johns Hopkins Medicine). With chemotherapy and, when possible, surgery, survival can extend, but overall rates remain low.

These figures show that treatment advances have not yet overcome the challenge of late diagnosis.

What usually kills a person with pancreatic cancer?

The disease often causes death through complications. According to the National Institutes of Health (US federal medical research agency), common causes include liver failure (when cancer blocks bile ducts), cachexia (severe wasting), infection (from blocked bile ducts), and bleeding from tumor invasion into blood vessels. The aggressive nature and advanced stage at diagnosis mean that the cancer has often already spread to critical organs by the time it’s found.

The pattern underscores why early detection remains the single most effective lever against mortality.

“Stage IV pancreatic cancer has a five-year survival rate of 3.2 percent.”

— Johns Hopkins Medicine

“Survival rates are based on large groups of people and cannot predict individual outcomes.”

— American Cancer Society

For someone facing a pancreatic cancer diagnosis, the numbers paint a difficult picture — particularly for late-stage disease. But survival is not a single number: stage, age, and access to treatment create a wide range of outcomes. The single biggest lever remains earlier detection, which could dramatically shift these statistics. For patients and families, the implication is clear: push for a thorough evaluation of any persistent symptoms, and when diagnosed, seek care at a high-volume center experienced in pancreatic cancer. For related health context, see our article on What Is Internal Medicine.

Understanding the factors that influence prognosis begins with knowing what causes pancreatic cancer, as early detection remains critical for improving outcomes.

Frequently asked questions